ALBME

New Buprenorphine Practice Guidelines

The Department of Health and Human Services (HHS) recently relaxed its guidelines for prescribing buprenorphine treatment for opioid use disorder.  Practitioners who dispense or prescribe buprenorphine for the treatment of opioid use disorder (OUD) to 30 or fewer patients are now exempt from certification requirements related to training and the provision of psychosocial services.   

Submission and approval of a Notice of Intent is still necessary to use buprenorphine in the treatment of patients with OUD. 

The new guidelines do not change the rules regarding administering (not prescribing) buprenorphine in emergency department settings, and, consistent with applicable DEA regulations, ED practitioners are still permitted to administer buprenorphine within their facility for up to three consecutive days without a waiver.

Resources:

Substance Abuse and Mental Health Services Administration's (SAMHSA)  FAQs About the New Buprenorphine Practice Guidelines

HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to treatment for Opioid Use Disorder

HHS Notice-Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder

SAMHSA Buprenorphine Quick Start Guide (.pdf)